financetom
Business
financetom
/
Business
/
Two killed in underground explosion at Australian silver mine
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Two killed in underground explosion at Australian silver mine
Oct 27, 2025 7:27 PM

*

Explosion at Polymetals-owned Endeavor mine

*

Polymetals shares on trading halt

*

Mining operations at Endeavor suspended

(Adds Polymetals comments in paragraphs 4-6)

SYDNEY, Oct 28 (Reuters) - Two workers were killed and

another injured in an explosion at the recently reopened

Polymetals Resources-owned Endeavor silver, zinc and

lead mine in Australia on Tuesday, forcing the temporary

suspension of operations.

Emergency services were called to the remote mining town of

Cobar in the state of New South Wales, some 700 km (435 miles)

northwest of Sydney, after a critical workplace incident,

Australian authorities said.

Police said it believed a man in his 60s and a woman in her

20s died, while a second woman in her 20s was flown to the

hospital for minor injuries and shock. They have not been

formally identified.

Polymetals Executive Chairman Dave Sproule said he was

"shocked and saddened by the tragic incident".

"The site emergency response team has been activated, and we

are working with all relevant authorities. Mining operations

have been temporarily suspended," Sproule said in a statement.

Polymetals on Tuesday requested a two-day trading halt on

its shares.

The company did not specify what caused the explosion.

The mine had operated since 1982 but was closed for

maintenance in 2020. Polymetals bought the site in 2023 and

restarted mining operations this year, according to the

company's website.

New South Wales Premier Chris Minns said that although

mining safety has greatly improved, the deaths show that the

sector must never stop being vigilant about worker safety.

"This is a heartbreaking day for the Cobar community and

will be felt across the entire mining industry," Minns said in a

statement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ocugen Advances OCU200 Trial After Safety Board Review
Ocugen Advances OCU200 Trial After Safety Board Review
Mar 18, 2025
08:30 AM EDT, 03/18/2025 (MT Newswires) -- Ocugen ( OCGN ) said Tuesday that an independent safety board reviewed data from the first dosing group in its phase 1 trial of OCU200 for diabetic macular edema and approved advancing to the second group. The company said the trial is testing OCU200, a fusion protein combining two human proteins, in patients...
RedHill Biopharma Plans to File for UK Approval of H.Pylori Treatment
RedHill Biopharma Plans to File for UK Approval of H.Pylori Treatment
Mar 18, 2025
08:01 AM EDT, 03/18/2025 (MT Newswires) -- RedHill Biopharma ( RDHL ) said Tuesday it intends to file a UK Marketing Authorisation Application for Talicia, which is used to treat helicobacter pylori infections. The application will reference the FDA's approval of Talicia through the MHRA's expedited International Recognition Procedure and should be approved by Q4, the company said. The company's...
Canada Nickel to Spin Out Net Smelter Returns on Certain Properties
Canada Nickel to Spin Out Net Smelter Returns on Certain Properties
Mar 18, 2025
08:35 AM EDT, 03/18/2025 (MT Newswires) -- Canada Nickel ( CNIKF ) on Tuesday said it created a new royalty company to hold net smelter return (NSR) royalties on most of its regional exploration properties in the Timmins Nickel district. The company signed a binding letter of intent with Edmiston Drive Capital (EDCC) to create the new company called RoyaltyCo....
Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy
Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy
Mar 18, 2025
08:37 AM EDT, 03/18/2025 (MT Newswires) -- Actinium Pharmaceuticals ( ATNM ) said Tuesday it is launching a clinical program consisting of trials studying Actimab-A in combination with either Merck's ( MRK ) Keytruda or Bristol Myers Squibb's ( BMY ) Opdivo for the treatment of multiple solid tumors. Actimab-A is meant to improve the efficacy of the immunotherapies by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved